BOSTON, April 2 /PRNewswire-FirstCall/ -- Perceptive Informatics, the industry’s leading eClinical solutions provider and a subsidiary of PAREXEL International Corporation , today announced that it has expanded the number of languages supported by its ClinPhone Interactive Web Response System (IWRS) including Japanese Kanji, the Chinese characters used in the Japanese writing system. Perceptive Informatics has experienced increased demand to incorporate Japanese Kanji into its IWRS due to the growing importance of the Asia/Pacific region in biopharmaceutical development. With this latest enhancement, Perceptive’s IWRS now supports over 80 languages via the web including the Chinese, Greek, Hebrew, Hungarian, Korean, Polish, Romanian, Russian, Slovak, Thai, Turkish and Ukrainian languages.
“Perceptive is meeting increased client demand for innovative technology that facilitates the conduct of large-scale global trials and web-based data collection. Some of the languages we have added to this IWRS enhancement correspond with the growth in trials being conducted in emerging regions,” said Todd Kole, Vice President, Interactive Voice and Web Response Systems, Perceptive Informatics.
Perceptive’s IWRS can now support clinical trials worldwide that include multiple languages and require real-time, web-based data collection. The Perceptive Informatics data center provides 24/7 global support for clinical trials involving multiple countries, time zones and languages. The IWRS platform powers Perceptive’s Randomization and Trial Supply Management (RTSM) technologies, which offer validated randomization methods, automated inventory control, dispensing and titration management, emergency code break capabilities and real-time supply reporting. The web interface of the IWRS allows for integration with Perceptive’s Electronic Data Capture (EDC) system and Clinical Trial Management Systems (CTMS) as part of its eClinical platform.
The IWRS complements the ClinPhone Interactive Voice Response System (IVRS), enabling Internet and telephone access and allowing end-users to perform study activities via one or both interfaces. Both methods provide secure access, a detailed audit trail, transaction logging and compliance with FDA 21 CRF Part 11. For more information about the IVR/IWR solutions from Perceptive Informatics, visit www.perceptive.com.
About Perceptive Informatics
Perceptive Informatics, a subsidiary of PAREXEL, is the industry’s leading eClinical solutions provider. Perceptive Informatics offers unprecedented access to innovative eClinical technologies and resources, providing clinical trial sponsors, CROs, and other service providers with the benefits of an extensive line of products and services throughout the entire clinical development lifecycle. In August, 2008 Perceptive was joined with ClinPhone plc, and the newly combined organization offers eClinical software and services that increase the efficiency and productivity of clinical research. Perceptive’s expansive product portfolio includes Interactive Voice and Web Response Systems (IVRS/IWRS), Medical Imaging, Electronic Data Capture (EDC) systems, Clinical Trial Management Systems (CTMS) and Electronic Patient Reported Outcomes (ePRO) solutions, as well as eClinical systems integration and implementation services. For more information about Perceptive Informatics, visit www.perceptive.com.
About PAREXEL International
PAREXEL International Corporation is a leading global biopharmaceutical services organization, providing a broad range of knowledge-based contract research, medical communications and consulting services to the worldwide pharmaceutical, biotechnology and medical device industries. Committed to providing solutions that expedite time-to-market and peak-market penetration, PAREXEL has developed significant expertise across the development and commercialization continuum, from drug development and regulatory consulting to clinical pharmacology, clinical trials management, medical education and reimbursement. Perceptive Informatics, Inc., a subsidiary of PAREXEL, provides advanced technology solutions, including medical imaging, to facilitate the clinical development process. Headquartered near Boston, Massachusetts, PAREXEL operates in 71 locations throughout 51 countries around the world, and has over 9,250 employees. For more information about PAREXEL International visit www.PAREXEL.com.
This release contains “forward-looking” statements regarding future results and events. For this purpose, any statements contained herein that are not statements of historical fact may be deemed forward-looking statements. Without limiting the foregoing, the words “believes,” “anticipates,” “plans,” “expects,” “intends,” “appears,” “estimates,” “projects,” “targets,” and similar expressions are also intended to identify forward-looking statements. The forward-looking statements in this release involve a number of risks and uncertainties. The Company’s actual future results may differ significantly from the results discussed in the forward-looking statements contained in this release. Important factors that might cause such a difference include, but are not limited to, risks associated with: actual operating performance; actual expense savings and other operating improvements resulting from recent restructurings; the loss, modification, or delay of contracts which would, among other things, adversely impact the Company’s recognition of revenue included in backlog; the Company’s dependence on certain industries and clients; the Company’s ability to win new business, manage growth and costs, and attract and retain employees; the Company’s ability to complete additional acquisitions and to integrate newly acquired businesses or enter into new lines of business, including, but not limited to, the successful business integration and anticipated synergy achievements in connection with the ClinPhone acquisition; the impact on the Company’s business of government regulation of the drug, medical device and biotechnology industry; consolidation within the pharmaceutical industry and competition within the biopharmaceutical services industry; the potential for significant liability to clients and third parties; the potential adverse impact of health care reform; and the effects of exchange rate fluctuations and other international economic, political, and other risks. Such factors and others are discussed more fully in the section entitled “Risk Factors” of the Company’s Quarterly Report on Form 10-Q for the quarter ended December 31, 2008 as filed with the SEC on February 9, 2009, which “Risk Factors” discussion is incorporated by reference in this press release. The forward-looking statements included in this press release represent the Company’s estimates as of the date of this release. The Company specifically disclaims any obligation to update these forward-looking statements in the future. These forward-looking statements should not be relied upon as representing the Company’s estimates or views as of any date subsequent to the date of this press release.
PAREXEL is a registered trademark of PAREXEL International Corporation, and Perceptive Informatics is a trademark of Perceptive Informatics, Inc. All other names or marks may be registered trademarks or trademarks of PAREXEL International Corporation, Perceptive Informatics, Inc. or their respective owners and are hereby acknowledged.
CONTACT: Jennifer Baird, Senior Director of Public Relations of PAREXEL
International, +1-781-434-4409, Jennifer.Baird@PAREXEL.com, or Rebecca
Passo of SHIFT Communications for PAREXEL International, +1-617-779-1817,
rpasso@shiftcomm.com
Web site: http://www.parexel.com/
http://www.perceptive.com/
